Form 4 for AMKR AMKOR TECHNOLOGY, INC.
Accepted 2024-02-26 00:00:00 ET · period of report 2024-02-22 · accession 0001047127-24-000046 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-02-26 | 2024-02-22 | AMKR | Rutten Guillaume Marie Jean | Pres, CEO, Dir | M - OptEx | $10.85 | +15.0K | 148.7K | +11% | +$162.7K |
| D | 2024-02-26 | 2024-02-22 | AMKR | Rutten Guillaume Marie Jean | Pres, CEO, Dir | S - Sale+OE | $30.63 | -25.0K | 123.7K | -17% | -$765.8K |
| D | 2024-02-26 | 2024-02-23 | AMKR | Rutten Guillaume Marie Jean | Pres, CEO, Dir | A - Grant | $0.00 | +10.7K | 134.5K | +9% | $0 |
| DM | 2024-02-26 | 2024-02-22+ | AMKR | Rutten Guillaume Marie Jean | Pres, CEO, Dir | M - OptEx | $0.00 | -25.7K | 98.1K | -21% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-22 | M | A | 10,625 | $9.48 | 144,353 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-22 | M | A | 4,375 | $14.17 | 148,728 | D | — | — | |
| 3 | Common | Common Stock | 2024-02-22 | S | D | 25,000 | $30.63 | 123,728 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.40 to $31.00. The Reporting Person hereby undertakes to provide, upon request, to the staff of the Securities and Exchange Commission, Amkor Technology, Inc. (the "Issuer"), or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. |
| 4 | Common | Common Stock | 2024-02-23 | A | A | 10,748 | $0.00 | 134,476 | D | — | — | |
| 5 | Derivative | Employee Stock Option (Right-to-Buy) | 2024-02-22 | M | D | 10,625 | $0.00 | 0 | D | $9.48 · 2020-02-15 to 2029-02-15 | 10,625 Common Stock | (F3) On March 17, 2023, the Reporting Person filed a Form 4 which inadvertently reported that the Reporting Person beneficially owned 15,265 2019 Options Shares (as defined below) as of March 15, 2023, instead of 15,625. As of February 22, 2024, the Reporting Person beneficially owned 0 2019 Option Shares. (F4) This stock option (the "2019 Option") to acquire 150,000 shares of the Issuer's common stock (the "2019 Option Shares") was granted on February 15, 2019 (the "2019 Option Grant Date") and vested over four years as follows: (i) with respect to 25% of the 2019 Option Shares, on the first anniversary of the 2019 Option Grant Date; and (ii) with respect to the remainder of the 2019 Option Shares, in equal quarterly installments thereafter, such that 100% of the 2019 Option vested on the fourth anniversary of the 2019 Option Grant Date. |
| 6 | Derivative | Restricted Stock Units | 2024-02-23 | M | D | 10,748 | $0.00 | 21,496 | D | $0.00 · — to — | 10,748 Common Stock | (F6) On February 24, 2022 (the "RSU Grant Date"), the Reporting Person was granted 42,992 time-vested restricted stock units ("RSUs") pursuant to the Issuer's 2021 Equity Incentive Plan, as amended, and the applicable award agreement. The RSUs convert into shares of the Issuer's common stock on a one-to-one basis and vest in four equal annual installments beginning on the first anniversary of the RSU Grant Date. |
| 7 | Derivative | Employee Stock Option (Right-to-Buy) | 2024-02-22 | M | D | 4,375 | $0.00 | 98,125 | D | $14.17 · 2020-10-30 to 2030-07-30 | 4,375 Common Stock | (F5) This stock option (the "2020 Option") to acquire 375,000 shares of the Issuer's common stock was granted on July 30, 2020 (the "2020 Option Grant Date") and vested in equal quarterly installments over three years, such that 100% of the 2020 Option vested on the third anniversary of the 2020 Option Grant Date. |